ADARx Pharmaceuticals, Inc. (ADRX) Stock Ticker
ADRX right now
Market factors today
Unlock the full ADRX picture
About ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
ADRX stock facts
| Ticker symbol | ADRX |
| Exchange | NASDAQ |
| Sector | Industrials |
| Industry | Specialty Business Services |
| Market cap | $2.1B |
| CEO | Zhen Li |
| Headquarters | San Diego, CA, US |
| IPO date | 2026-09-25 |
| Website | www.adarx.com |
What you can see for ADRX on Tickr
Live ADRX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ADRX report.
Rankings
FAQ
What is the ticker symbol for ADARx Pharmaceuticals, Inc.?
The ticker symbol for ADARx Pharmaceuticals, Inc. is ADRX, listed on the NASDAQ.
What is ADRX?
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.